Degenerative disease

From Wikipedia, the free encyclopedia
  (Redirected from Degenerative diseases)
Jump to navigation Jump to search

Degenerative disease is the result of a continuous process based on degenerative cell changes, affecting tissues or organs, which will increasingly deteriorate over time.[1]

In neurodegerative diseases cells of the central nervous system stop working or die via neurodegeneration. An example of this is Alzheimer's disease.[2] The other two common groups of degenerative diseases are those that affect circulatory system (e.g. coronary artery disease) and neoplastic diseases (e.g. cancers).[1]

Many degenerative diseases exist and some are related to aging. Normal bodily wear or lifestyle choices (such as exercise or eating habits) may worsen degenerative diseases, but this depends on the disease.[1] Sometimes the main or partial cause behind such diseases is genetic.[3] Thus some are clearly hereditary like Huntington's disease.[4] Sometimes the cause is viruses, poisons or other chemicals. The cause may also be unknown.[3]

Some degenerative diseases can be cured, but not always. It might still be possible to alleviate the symptoms.[1]

Examples[edit]

See also[edit]

References[edit]

  1. ^ a b c d e "What is Degenerative Disease". docdoc.com.sg. Archived from the original on 2018-09-17. Retrieved 2018-09-17. 
  2. ^ "neurodegenerative disorder". National Cancer Institute. 2011-02-02. Archived from the original on 2018-04-23. Retrieved 2018-09-17. 
  3. ^ a b "Neurodegenerative Diseases". Archived from the original on 2018-07-28. Retrieved 2018-09-17. 
  4. ^ a b Nopoulos, PC (2016). "Huntington disease: a single-gene degenerative disorder of the striatum". Dialogues in Clinical Neuroscience. 18 (1): 91–98. ISSN 1294-8322. PMC 4826775Freely accessible. PMID 27069383. 
  5. ^ a b c d Soto, C; Satani, N (2011). "The intricate mechanisms of neurodegeneration in prion diseases". Trends in Molecular Medicine. 17 (1): 14–24. doi:10.1016/j.molmed.2010.09.001. ISSN 1471-4914. PMC 3056171Freely accessible. PMID 20889378. 
  6. ^ Patzkó, Á; Shy, ME (2011). "Update on Charcot-Marie-Tooth Disease". Current Neurology and Neuroscience Reports. 11 (1): 78–88. doi:10.1007/s11910-010-0158-7. ISSN 1528-4042. PMC 3685483Freely accessible. PMID 21080241. 
  7. ^ Maroon, JC; Winkelman, R; Bost, J; Amos, A; Mathyssek, C; Miele, V (2015-02-11). "Chronic Traumatic Encephalopathy in Contact Sports: A Systematic Review of All Reported Pathological Cases". PLoS ONE. 10 (2): e0117338. doi:10.1371/journal.pone.0117338. ISSN 1932-6203. PMC 4324991Freely accessible. PMID 25671598. 
  8. ^ Fraser-Pitt, D; O’Neil, D (2015). "Cystic fibrosis – a multiorgan protein misfolding disease". Future Science OA. 1 (2): FSO57. doi:10.4155/fso.15.57. ISSN 2056-5623. PMC 5137970Freely accessible. PMID 28031875. 
  9. ^ "Cytochrome c oxidase deficiency". rarediseases.info.nih.gov. Archived from the original on 2017-10-22. Retrieved 2018-09-17. 
  10. ^ "Ehlers-Danlos syndromes". rarediseases.info.nih.gov. Archived from the original on 2018-06-16. Retrieved 2018-09-17. 
  11. ^ Delatycki, M; Williamson, R; Forrest, S (2000). "Friedreich ataxia: an overview". Journal of Medical Genetics. 37 (1): 1–8. doi:10.1136/jmg.37.1.1. ISSN 0022-2593. PMC 1734457Freely accessible. PMID 10633128. 
  12. ^ Warren, JD; Rohrer, JD; Rossor, MN (2013-08-06). "Frontotemporal dementia". The BMJ. 347: f4827. doi:10.1136/bmj.f4827. ISSN 0959-8138. PMC 3735339Freely accessible. PMID 23920254. 
  13. ^ Barik, R (2016). "Degenerative aortic valve disease and coronary artery disease are either side of a coin". Indian Heart Journal. 68 (3): 432. doi:10.1016/j.ihj.2015.09.010. ISSN 0019-4832. PMC 4911461Freely accessible. PMID 27316510. 
  14. ^ Li, H; Zou, Y; Bao, X; Wang, H; Wang, J; Jin, H; Che, Y; Tang, X (2016). "Monozygotic twins with infantile neuroaxonal dystrophy: A case report and literature review". Experimental and Therapeutic Medicine. 12 (5): 3387–3389. doi:10.3892/etm.2016.3761. ISSN 1792-0981. PMC 5103811Freely accessible. PMID 27882168. 
  15. ^ Davidson, AE; Hayes, S; Hardcastle, AJ; Tuft, SJ (2014). "The pathogenesis of keratoconus". Eye. 28 (2): 189–195. doi:10.1038/eye.2013.278. ISSN 0950-222X. PMC 3930280Freely accessible. PMID 24357835. 
  16. ^ Wallang, BS; Das, S (2013). "Keratoglobus". Eye. 27 (9): 1004–1012. doi:10.1038/eye.2013.130. ISSN 0950-222X. PMC 3772364Freely accessible. PMID 23807384. 
  17. ^ van der Knaap, MS; Bugiani, M (2017). "Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms". Acta Neuropathologica. 134 (3): 351–382. doi:10.1007/s00401-017-1739-1. ISSN 0001-6322. PMC 5563342Freely accessible. PMID 28638987. 
  18. ^ Anand, A; Sharma, K; Chen, W; Sharma, NK (2014). "Using Current Data to Define New Approach in Age Related Macular Degeneration: Need to Accelerate Translational Research". Current Genomics. 15 (4): 266–277. doi:10.2174/1389202915666140516204512. ISSN 1389-2029. PMC 4133950Freely accessible. PMID 25132797. 
  19. ^ Gao, L; Luo, F; Hui, R; Zhou, X (2010). "Recent molecular biological progress in Marfan syndrome and Marfan-associated disorders". Ageing Research Reviews. 9 (3): 363–368. doi:10.1016/j.arr.2009.09.001. ISSN 1568-1637. PMID 19772952. 
  20. ^ "MELAS Syndrome". NORD (National Organization for Rare Disorders). Archived from the original on 2017-02-20. Retrieved 2018-09-17. 
  21. ^ El-Hattab, AW; Scaglia, F (2013). "Mitochondrial DNA Depletion Syndromes: Review and Updates of Genetic Basis, Manifestations, and Therapeutic Options". Neurotherapeutics. 10 (2): 186–198. doi:10.1007/s13311-013-0177-6. ISSN 1933-7213. PMC 3625391Freely accessible. PMID 23385875. 
  22. ^ Fitzner, D; Simons, M (2010). "Chronic Progressive Multiple Sclerosis – Pathogenesis of Neurodegeneration and Therapeutic Strategies". Current Neuropharmacology. 8 (3): 305–315. doi:10.2174/157015910792246218. ISSN 1570-159X. PMC 3001222Freely accessible. PMID 21358979. 
  23. ^ Ubhi, K; Low, P; Masliah, E (2011). "Multiple System Atrophy: A Clinical and Neuropathological Perspective". Trends in Neurosciences. 34 (11): 581–590. doi:10.1016/j.tins.2011.08.003. ISSN 0166-2236. PMC 3200496Freely accessible. PMID 21962754. 
  24. ^ Shin, J; Tajrishi, MM; Ogura, Y; Kumar, A (2013). "Wasting Mechanisms in Muscular Dystrophy". The International Journal of Biochemistry & Cell Biology. 45 (10): 2266–2279. doi:10.1016/j.biocel.2013.05.001. ISSN 1357-2725. PMC 3759654Freely accessible. PMID 23669245. 
  25. ^ Mole, SE; Williams, Ruth E. (1993), Adam, Margaret P.; Ardinger, Holly H.; Pagon, Roberta A.; Wallace, Stephanie E., eds., "Neuronal Ceroid-Lipofuscinoses", GeneReviews®, University of Washington, Seattle, PMID 20301601, retrieved 2018-09-17 
  26. ^ Evans, WRH; Hendriksz, CJ (2017). "Niemann–Pick type C disease – the tip of the iceberg? A review of neuropsychiatric presentation, diagnosis and treatment". BJPsych Bulletin. 41 (2): 109–114. doi:10.1192/pb.bp.116.054072. ISSN 2056-4694. PMC 5376728Freely accessible. PMID 28400970. 
  27. ^ a b Shen, Y; Zhang, Y; Shen, L (2013-04-15). "Postmenopausal women with osteoporosis and osteoarthritis show different microstructural characteristics of trabecular bone in proximal tibia using high-resolution magnetic resonance imaging at 3 tesla". BMC Musculoskeletal Disorders. 14: 136. doi:10.1186/1471-2474-14-136. ISSN 1471-2474. PMC 3659090Freely accessible. PMID 23587336. 
  28. ^ Bazan, IS; Fares, WH (2015-08-17). "Pulmonary hypertension: diagnostic and therapeutic challenges". Therapeutics and Clinical Risk Management. 11: 1221–1233. doi:10.2147/TCRM.S74881. ISSN 1176-6336. PMC 4544628Freely accessible. PMID 26316767. 
  29. ^ Owolabi, LF (2013). "Progressive Supranuclear Palsy Misdiagnosed as Parkinson's Disease: A Case Report and Review of Literature". Annals of Medical and Health Sciences Research. 3 (Suppl1): S44–S47. doi:10.4103/2141-9248.121221. ISSN 2141-9248. PMC 3853608Freely accessible. PMID 24349849. 
  30. ^ Hamel, C (2006-10-11). "Retinitis pigmentosa". Orphanet Journal of Rare Diseases. 1: 40. doi:10.1186/1750-1172-1-40. ISSN 1750-1172. PMC 1621055Freely accessible. PMID 17032466. 
  31. ^ Abdel-Ahad, P; El Chammai, M; Fneich, A; Issa, R; Kabbara, W; Richa, S (2016). "Les manifestations psychiatriques dans la polyarthrite rhumatoïde". L'Encéphale. 42 (2): 172–176. doi:10.1016/j.encep.2015.12.008. ISSN 0013-7006. PMID 26850214. 
  32. ^ a b Walia, JP; Altaleb, N; Bello, A; Kruck, C; LaFave, MC; Varshney, GK; Burgess, SM; Chowdhury, B; Hurlbut, D (2015). "Long-Term Correction of Sandhoff Disease Following Intravenous Delivery of rAAV9 to Mouse Neonates". Molecular Therapy. 23 (3): 414–422. doi:10.1038/mt.2014.240. ISSN 1525-0016. PMC 4351464Freely accessible. PMID 25515709. 
  33. ^ Simone, C; Ramirez, A; Bucchia, M; Rinchetti, P; Rideout, H; Papadimitriou, D; Re, DB; Corti, S (2016). "Is Spinal Muscular Atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?". Cellular and Molecular Life Sciences : CMLS. 73 (5): 1003–1020. doi:10.1007/s00018-015-2106-9. ISSN 1420-682X. PMC 4756905Freely accessible. PMID 26681261. 
  34. ^ Jafri, SK; Kumar, R; Ibrahim, SH (2018-06-26). "Subacute sclerosing panencephalitis – current perspectives". Pediatric Health, Medicine and Therapeutics. 9: 67–71. doi:10.2147/PHMT.S126293. ISSN 1179-9927. PMC 6027681Freely accessible. PMID 29985487. 
  35. ^ Korczyn, AD; Vakhapova, V; Grinberg, LT (2012-11-15). "Vascular dementia". Journal of the Neurological Sciences. 322 (1–2): 2–10. doi:10.1016/j.jns.2012.03.027. ISSN 0022-510X. PMC 3435447Freely accessible. PMID 22575403.